| Joaquin Arambula, | |
|
1141 Rose Ave, Selma, CA 93662-3241 | |
| (559) 891-6244 | |
| Not Available |
| Full Name | Joaquin Arambula |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1141 Rose Ave, Selma, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871658641 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A89417 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joaquin Arambula, 1052 E Hogan Ave, Fresno, CA 93720-5933 Ph: (559) 312-6655 | Joaquin Arambula, 1141 Rose Ave, Selma, CA 93662-3241 Ph: (559) 891-6244 |
News Archive
The Nutritional Immunology and Molecular Medicine Laboratory (NIMML) research team at Virginia Tech has discovered important new information on the efficacy of conjugated linoleic acid (CLA) in treating Crohn's disease, a form of inflammatory bowel disease (IBD). CLA is a naturally occurring acid found in meat and dairy products known for its anti-cancer and immune modulatory properties.
CRANN, the Science Foundation Ireland funded nanoscience research institute, based at Trinity College Dublin, has today announced a new commercial partnership worth over €130,000 with Merck Millipore, a biotech and pharmaceutical company based in Cork. As part of the research programmes, CRANN will assist Merck Millipore to further develop the nanostructures of their products' artificial membranes, that are widely used for medical and diagnostic devices, and to deliver new products with improved membrane performances. Artificial membranes are used in a wide array of products such as lab filtration devices, antibody screening kits and blood typing products.
GTC Biotherapeutics, Inc. announced today that it has signed a definitive agreement whereby the Company has regained US commercialization rights to ATryn from Lundbeck, Inc., a wholly owned subsidiary of H. Lundbeck A/S in Denmark.
Cancer Research UK scientists have discovered that cervical cancer patients who have a mixture of different genetic faults in their tumour at the start of treatment may be more likely to relapse, according to a study published in the British Journal of Cancer today.
The future is looking good for drugs designed to combat Alzheimer's disease. EPFL scientists have unveiled how two classes of drug compounds currently in clinical trials work to fight the disease. Their research suggests that these compounds target the disease-causing peptides with high precision and with minimal side-effects.
› Verified 2 days ago
Navid Ahmadian, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1141 Rose Ave, Selma, CA 93662 Phone: 559-891-6244 | |
Jason Jackson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1141 Rose Ave, Selma, CA 93662 Phone: 559-856-6310 | |
Earl C Hackett, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1141 Rose Ave, Selma, CA 93662 Phone: 559-891-2238 | |
Aaron Jeffrey Carter, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1141 Rose Ave, Selma, CA 93662 Phone: 559-856-6310 | |
Dr. Angelo Nicholas Heropoulos, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1141 Rose Ave, Selma, CA 93662 Phone: 559-891-6244 | |
Brian Woo, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1141 Rose Ave, Selma, CA 93662 Phone: 559-891-1000 | |
Thomas Lauck, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1041 Rose Ave, Selma, CA 93662 Phone: 559-891-6345 Fax: 559-891-6346 |